Global and United States Restless Legs Syndrome Market Report & Forecast 2024-2031

Report ID: 1844972 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Restless Legs Syndrome Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Restless Legs Syndrome Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Restless Legs Syndrome Market Size for the Year 2017-2028
        1.2.2 Global Restless Legs Syndrome Market Size for the Year 2017-2028
    1.3 Restless Legs Syndrome Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Restless Legs Syndrome in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Restless Legs Syndrome Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Restless Legs Syndrome Market Dynamics
        1.4.1 Restless Legs Syndrome Industry Trends
        1.4.2 Restless Legs Syndrome Market Drivers
        1.4.3 Restless Legs Syndrome Market Challenges
        1.4.4 Restless Legs Syndrome Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Restless Legs Syndrome by Type
    2.1 Restless Legs Syndrome Market Segment by Type
        2.1.1 Pharmacological Therapy
        2.1.2 Non-Pharmacological Therapy
    2.2 Global Restless Legs Syndrome Market Size by Type (2017, 2022 & 2028)
    2.3 Global Restless Legs Syndrome Market Size by Type (2017-2028)
    2.4 United States Restless Legs Syndrome Market Size by Type (2017, 2022 & 2028)
    2.5 United States Restless Legs Syndrome Market Size by Type (2017-2028)
3 Restless Legs Syndrome by Application
    3.1 Restless Legs Syndrome Market Segment by Application
        3.1.1 Below 35 YearsOld
        3.1.2 35-50 Years Old
        3.1.3 Above50 YearsOld
    3.2 Global Restless Legs Syndrome Market Size by Application (2017, 2022 & 2028)
    3.3 Global Restless Legs Syndrome Market Size by Application (2017-2028)
    3.4 United States Restless Legs Syndrome Market Size by Application (2017, 2022 & 2028)
    3.5 United States Restless Legs Syndrome Market Size by Application (2017-2028)
4 Global Restless Legs Syndrome Competitor Landscape by Company
    4.1 Global Restless Legs Syndrome Market Size by Company
        4.1.1 Top Global Restless Legs Syndrome Companies Ranked by Revenue (2021)
        4.1.2 Global Restless Legs Syndrome Revenue by Player (2017-2022)
    4.2 Global Restless Legs Syndrome Concentration Ratio (CR)
        4.2.1 Restless Legs Syndrome Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Restless Legs Syndrome in 2021
        4.2.3 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Restless Legs Syndrome Headquarters, Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Restless Legs Syndrome Headquarters and Area Served
        4.3.2 Global Restless Legs Syndrome Companies Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Restless Legs Syndrome Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Restless Legs Syndrome Market Size by Company
        4.5.1 Top Restless Legs Syndrome Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Restless Legs Syndrome Revenue by Players (2020, 2021 & 2022)
5 Global Restless Legs Syndrome Market Size by Region
    5.1 Global Restless Legs Syndrome Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Restless Legs Syndrome Market Size by Region (2017-2028)
        5.2.1 Global Restless Legs Syndrome Market Size by Region: 2017-2022
        5.2.2 Global Restless Legs Syndrome Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Restless Legs Syndrome Market Size YoY Growth 2017-2028
        6.1.2 North America Restless Legs Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Restless Legs Syndrome Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Restless Legs Syndrome Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe Restless Legs Syndrome Market Size YoY Growth 2017-2028
        6.3.2 Europe Restless Legs Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Restless Legs Syndrome Market Size YoY Growth 2017-2028
        6.4.2 Latin America Restless Legs Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Restless Legs Syndrome Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Restless Legs Syndrome Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 GlaxoSmithKline plc.
        7.1.1 GlaxoSmithKline plc. Company Details
        7.1.2 GlaxoSmithKline plc. Business Overview
        7.1.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction
        7.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2017-2022)
        7.1.5 GlaxoSmithKline plc. Recent Development
    7.2 Ligand Pharmaceuticals Incorporated
        7.2.1 Ligand Pharmaceuticals Incorporated Company Details
        7.2.2 Ligand Pharmaceuticals Incorporated Business Overview
        7.2.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction
        7.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2017-2022)
        7.2.5 Ligand Pharmaceuticals Incorporated Recent Development
    7.3 axxonis Pharma AG
        7.3.1 axxonis Pharma AG Company Details
        7.3.2 axxonis Pharma AG Business Overview
        7.3.3 axxonis Pharma AG Restless Legs Syndrome Introduction
        7.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2017-2022)
        7.3.5 axxonis Pharma AG Recent Development
    7.4 Kyowa Hakko Kirin
        7.4.1 Kyowa Hakko Kirin Company Details
        7.4.2 Kyowa Hakko Kirin Business Overview
        7.4.3 Kyowa Hakko Kirin Restless Legs Syndrome Introduction
        7.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2017-2022)
        7.4.5 Kyowa Hakko Kirin Recent Development
    7.5 Jazz Pharmaceuticals
        7.5.1 Jazz Pharmaceuticals Company Details
        7.5.2 Jazz Pharmaceuticals Business Overview
        7.5.3 Jazz Pharmaceuticals Restless Legs Syndrome Introduction
        7.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022)
        7.5.5 Jazz Pharmaceuticals Recent Development
    7.6 Omeros Corporation
        7.6.1 Omeros Corporation Company Details
        7.6.2 Omeros Corporation Business Overview
        7.6.3 Omeros Corporation Restless Legs Syndrome Introduction
        7.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2017-2022)
        7.6.5 Omeros Corporation Recent Development
    7.7 Manhattan Pharmaceuticals
        7.7.1 Manhattan Pharmaceuticals Company Details
        7.7.2 Manhattan Pharmaceuticals Business Overview
        7.7.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction
        7.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022)
        7.7.5 Manhattan Pharmaceuticals Recent Development
    7.8 Boehringer Ingelheim GmbH
        7.8.1 Boehringer Ingelheim GmbH Company Details
        7.8.2 Boehringer Ingelheim GmbH Business Overview
        7.8.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction
        7.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2017-2022)
        7.8.5 Boehringer Ingelheim GmbH Recent Development
    7.9 UCB SA
        7.9.1 UCB SA Company Details
        7.9.2 UCB SA Business Overview
        7.9.3 UCB SA Restless Legs Syndrome Introduction
        7.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2017-2022)
        7.9.5 UCB SA Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Restless Legs Syndrome Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Restless Legs Syndrome Market Trends
    Table 3. Restless Legs Syndrome Market Drivers
    Table 4. Restless Legs Syndrome Market Challenges
    Table 5. Restless Legs Syndrome Market Restraints
    Table 6. Global Restless Legs Syndrome Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Restless Legs Syndrome Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Restless Legs Syndrome Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Restless Legs Syndrome Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Restless Legs Syndrome Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Restless Legs Syndrome Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Restless Legs Syndrome Revenue Share by Player, 2017-2022
    Table 13. Global Restless Legs Syndrome Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Restless Legs Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2021)
    Table 15. Top Players of Restless Legs Syndrome in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Restless Legs Syndrome Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Restless Legs Syndrome Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Restless Legs Syndrome Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Restless Legs Syndrome Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Restless Legs Syndrome Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Restless Legs Syndrome Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Restless Legs Syndrome Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Restless Legs Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Restless Legs Syndrome Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Restless Legs Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Restless Legs Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Restless Legs Syndrome Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. GlaxoSmithKline plc. Company Details
    Table 31. GlaxoSmithKline plc. Business Overview
    Table 32. GlaxoSmithKline plc. Restless Legs Syndrome Product
    Table 33. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 34. GlaxoSmithKline plc. Recent Development
    Table 35. Ligand Pharmaceuticals Incorporated Company Details
    Table 36. Ligand Pharmaceuticals Incorporated Business Overview
    Table 37. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product
    Table 38. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 39. Ligand Pharmaceuticals Incorporated Recent Development
    Table 40. axxonis Pharma AG Company Details
    Table 41. axxonis Pharma AG Business Overview
    Table 42. axxonis Pharma AG Restless Legs Syndrome Product
    Table 43. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 44. axxonis Pharma AG Recent Development
    Table 45. Kyowa Hakko Kirin Company Details
    Table 46. Kyowa Hakko Kirin Business Overview
    Table 47. Kyowa Hakko Kirin Restless Legs Syndrome Product
    Table 48. Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 49. Kyowa Hakko Kirin Recent Development
    Table 50. Jazz Pharmaceuticals Company Details
    Table 51. Jazz Pharmaceuticals Business Overview
    Table 52. Jazz Pharmaceuticals Restless Legs Syndrome Product
    Table 53. Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 54. Jazz Pharmaceuticals Recent Development
    Table 55. Omeros Corporation Company Details
    Table 56. Omeros Corporation Business Overview
    Table 57. Omeros Corporation Restless Legs Syndrome Product
    Table 58. Omeros Corporation Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 59. Omeros Corporation Recent Development
    Table 60. Manhattan Pharmaceuticals Company Details
    Table 61. Manhattan Pharmaceuticals Business Overview
    Table 62. Manhattan Pharmaceuticals Restless Legs Syndrome Product
    Table 63. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 64. Manhattan Pharmaceuticals Recent Development
    Table 65. Boehringer Ingelheim GmbH Company Details
    Table 66. Boehringer Ingelheim GmbH Business Overview
    Table 67. Boehringer Ingelheim GmbH Restless Legs Syndrome Product
    Table 68. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 69. Boehringer Ingelheim GmbH Recent Development
    Table 70. UCB SA Company Details
    Table 71. UCB SA Business Overview
    Table 72. UCB SA Restless Legs Syndrome Product
    Table 73. UCB SA Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
    Table 74. UCB SA Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Restless Legs Syndrome Product Picture
    Figure 2. Global Restless Legs Syndrome Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Restless Legs Syndrome Market Size 2017-2028 (US$ Million)
    Figure 4. United States Restless Legs Syndrome Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Restless Legs Syndrome Market Size 2017-2028 (US$ Million)
    Figure 6. United States Restless Legs Syndrome Market Share in Global 2017-2028
    Figure 7. Restless Legs Syndrome Report Years Considered
    Figure 8. Product Picture of Pharmacological Therapy
    Figure 9. Product Picture of Non-Pharmacological Therapy
    Figure 10. Global Restless Legs Syndrome Market Share by Type in 2022 & 2028
    Figure 11. Global Restless Legs Syndrome Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Restless Legs Syndrome Market Share by Type (2017-2028)
    Figure 13. United States Restless Legs Syndrome Market Share by Type in 2022 & 2028
    Figure 14. United States Restless Legs Syndrome Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Restless Legs Syndrome Market Share by Type (2017-2028)
    Figure 16. Product Picture of Below 35 YearsOld
    Figure 17. Product Picture of 35-50 Years Old
    Figure 18. Product Picture of Above50 YearsOld
    Figure 19. Global Restless Legs Syndrome Market Share by Application in 2022 & 2028
    Figure 20. Global Restless Legs Syndrome Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Restless Legs Syndrome Market Share by Application (2017-2028)
    Figure 22. United States Restless Legs Syndrome Market Share by Application in 2022 & 2028
    Figure 23. United States Restless Legs Syndrome Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Restless Legs Syndrome Market Share by Application (2017-2028)
    Figure 25. North America Restless Legs Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. United States Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Mexico Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Restless Legs Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. UK Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Restless Legs Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Vietnam Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Restless Legs Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Restless Legs Syndrome Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Restless Legs Syndrome Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 55. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 56. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 57. Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 58. Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 59. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 60. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 61. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 62. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline plc.
Ligand Pharmaceuticals Incorporated
axxonis Pharma AG
Kyowa Hakko Kirin
Jazz Pharmaceuticals
Omeros Corporation
Manhattan Pharmaceuticals
Boehringer Ingelheim GmbH
UCB SA
Frequently Asked Questions
Restless Legs Syndrome report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Restless Legs Syndrome report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Restless Legs Syndrome report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Polyester Strapping

Polyester Strapping market is segmented by region (country), players, by Type and by Application. ... Read More